Immunogenicity of Salmonella typhi Ty21a vaccine for young children.

An attenuated Salmonella typhi Ty21a vaccine was administered to 18 infants and toddlers (less than or equal to 24 months old) to determine its safety and immunogenicity. The vaccination (10(9) CFU per dose, three doses) was well tolerated. However, after the vaccination there was no evidence of a h...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Infect Immun
Autori principali:	Murphy, J R, Grez, L, Schlesinger, L, Ferreccio, C, Baqar, S, Muñoz, C, Wasserman, S S, Losonsky, G, Olson, J G, Levine, M M
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1991
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC259034/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1937790/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.59.11.4291-4293.1991
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!